Akhoundova D, Hiltbrunner S, Mader C, Förster R, Kraft J, Schwanhaüsser B et al (2020) 18F-FET PET for diagnosis of pseudoprogression of brain metastases in patients with non-small cell lung cancer. Clin Nucl Med. 45(2):113–117. https://doi.org/10.1097/RLU.0000000000002890
Article
PubMed
Google Scholar
Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC (2016) Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 18(9):1199–1208. https://doi.org/10.1093/neuonc/now058
Article
CAS
PubMed
PubMed Central
Google Scholar
Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019) 18F-fluciclovine PET/CT in suspected residual or recurrent high-grade glioma. Clin Nucl Med. 44(8):605–611. https://doi.org/10.1097/RLU.0000000000002641
Article
PubMed
Google Scholar
Ceccon G, Lohmann P, Stoffels G, Judov N, Filss CP, Rapp M, Bauer E, Hamisch C, Ruge MI, Kocher M, Kuchelmeister K, Sellhaus B, Sabel M, Fink GR, Shah NJ, Langen KJ, Galldiks N (2017) Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy. Neuro Oncol. 19(2):281–288. https://doi.org/10.1093/neuonc/now149
Article
CAS
PubMed
Google Scholar
Galldiks N, Law I, Pope WB, Arbizu J, Langen KJ (2017) The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy. NeuroImage Clin 13:386–394. Available from:. https://doi.org/10.1016/j.nicl.2016.12.020
Article
PubMed
Google Scholar
Galldiks N, Rapp M, Stoffels G, Dunkl V, Sabel M, Langen KJ (2013) Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging. Mol Imaging. 12(5):273–276
Article
PubMed
Google Scholar
Gempt J, Bette S, Buchmann N, Ryang YM, Förschler A, Pyka T, Wester HJ, Förster S, Meyer B, Ringel F (2015) Volumetric analysis of F-18-FET-PET imaging for brain metastases. World Neurosurg. 84(6):1790–1797. https://doi.org/10.1016/j.wneu.2015.07.067
Article
PubMed
Google Scholar
Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA (2011) An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Int J Radiat Oncol Biol Phys. 81(4):1049–1058. https://doi.org/10.1016/j.ijrobp.2010.07.002
Article
CAS
PubMed
Google Scholar
Habermeier A, Graf J, Sandhöfer BF, Boissel JP, Roesch F, Closs EI (2015) System l amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-l-tyrosine (FET). Amino Acids. 47(2):335–344. https://doi.org/10.1007/s00726-014-1863-3
Article
CAS
PubMed
Google Scholar
Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R (1999) Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 40(8):1367–1373
CAS
PubMed
Google Scholar
Helseth E, Meling T, Lundar T, Scheie D, Skullerud K, Lote K et al (2003) Intrakraniale svulster hos voksne. Tidsskr den Nor Laegeforening. 123(4):456–461
Google Scholar
Karlberg A, Berntsen EM, Johansen H, Myrthue M, Skjulsvik AJ, Reinertsen I et al (2017) Multimodal 18F-fluciclovine PET/MRI and ultrasound-guided neurosurgery of an anaplastic oligodendroglioma. World Neurosurg 108:989.e1–989.e8
Article
Google Scholar
Karlberg A, Berntsen EM, Johansen H, Skjulsvik AJ, Reinertsen I, Dai HY, Xiao Y, Rivaz H, Borghammer P, Solheim O, Eikenes L (2019) 18F-FACBC PET/MRI in diagnostic assessment and neurosurgery of gliomas. Clin Nucl Med. 44(7):550–559. https://doi.org/10.1097/RLU.0000000000002610
Article
PubMed
Google Scholar
Kondo A, Ishii H, Aoki S, Suzuki M, Nagasawa H, Kubota K, Minamimoto R, Arakawa A, Tominaga M, Arai H (2016) Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors. Ann Nucl Med. 30(9):608–618. https://doi.org/10.1007/s12149-016-1102-y
Article
CAS
PubMed
Google Scholar
Ladefoged CN, Hansen AE, Henriksen OM, Bruun FJ, Eikenes L, Øen SK et al (2020) AI-driven attenuation correction for brain PET/MRI: clinical evaluation of a dementia cohort and importance of the training group size. Neuroimage 222(November 2019):117221. Available from. https://doi.org/10.1016/j.neuroimage.2020.117221
Article
CAS
PubMed
Google Scholar
Law I, Albert NL, Arbizu J, Boellaard R, Drzezga A, Galldiks N, la Fougère C, Langen KJ, Lopci E, Lowe V, McConathy J, Quick HH, Sattler B, Schuster DM, Tonn JC, Weller M (2019) Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18 F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 46(3):540–557. https://doi.org/10.1007/s00259-018-4207-9
Article
CAS
PubMed
Google Scholar
Liu Q, Tong X, Wang J (2019) Management of brain metastases: history and the present. Chinese Neurosurg J. 5(1):1–8. https://doi.org/10.1186/s41016-018-0149-0
Article
Google Scholar
Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R (2020) F-Fluciclovine (18 F-FACBC) PET imaging of recurrent brain tumors. Eur J Nucl Med Mol Imaging. 47:1353–1367
Article
CAS
PubMed
Google Scholar
Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep. 14(1):48–54. https://doi.org/10.1007/s11912-011-0203-y
Article
PubMed
Google Scholar
Oka S, Okudaira H, Yoshida Y, Schuster DM, Goodman MM, Shirakami Y (2012) Transport mechanisms of trans-1-amino-3-fluoro[1-14C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol 39(1):109–119. Available from:. https://doi.org/10.1016/j.nucmedbio.2011.06.008
Article
CAS
PubMed
Google Scholar
Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, Schuster DM et al (2015) Corrigendum to “Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2” [Nucl. Med. Biol, 2013, 40, 670-675], doi: 10.1016/j.nucmedbio.2013.03.009. Nucl Med Biol 42(5):513–514. Available from:. https://doi.org/10.1016/j.nucmedbio.2014.12.013
Article
CAS
Google Scholar
Ono M, Oka S, Okudaira H, Schuster DM, Goodman MM, Kawai K, Shirakami Y (2013) Comparative evaluation of transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid and l-[methyl-11C]methionine in human glioma cell lines. Brain Res. 1535:24–37. Available from:. https://doi.org/10.1016/j.brainres.2013.08.037
Article
CAS
PubMed
Google Scholar
Papin-Michault C, Bonnetaud C, Dufour M, et al (2016) Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers. PLoS One. 11(6):e0157139. https://doi.org/10.1371/journal.pone.0157139
Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Müller HW et al (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain. 128(3):678–687. https://doi.org/10.1093/brain/awh399
Article
PubMed
Google Scholar
Pöpperl G, Kreth FW, Mehrkens JH, Herms J, Seelos K, Koch W, Gildehaus FJ, Kretzschmar HA, Tonn JC, Tatsch K (2007) FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging. 34(12):1933–1942. https://doi.org/10.1007/s00259-007-0534-y
Article
PubMed
Google Scholar
Stelzer KJ (2013) Epidemiology and prognosis of brain metastases. Surg Neurol Int 4:S192–202
Sun A, Liu X, Tang G (2018) Carbon-11 and fluorine-18 labeled amino acid tracers for positron emission tomography imaging of tumors. Front Chem. 5(January):1–16
Google Scholar
Tsuyuguchi N, Terakawa Y, Uda T, Nakajo K, Kanemura Y (2017) Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: a comparative study with L-methyl-11C-methionine PET imaging. Asia Ocean J Nucl Med Biol. 5(2):85–94. https://doi.org/10.22038/aojnmb.2017.8843
Article
PubMed
PubMed Central
Google Scholar
Unterrainer M, Galldiks N, Suchorska B, Kowalew LC, Wenter V, Schmid-Tannwald C, Niyazi M, Bartenstein P, Langen KJ, Albert NL (2017) 18F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis. J Nucl Med. 58(4):584–589. https://doi.org/10.2967/jnumed.116.180075
Article
CAS
PubMed
Google Scholar
Unterrainer M, Schweisthal F, Suchorska B, Wenter V, Schmid-Tannwald C, Fendler WP, Schuller U, Bartenstein P, Tonn JC, Albert NL (2016) Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma: does it make sense? J Nucl Med. 57(8):1177–1182. https://doi.org/10.2967/jnumed.115.171033
Article
CAS
PubMed
Google Scholar